UK study suggests Covid-19 vaccine gives immunity for 5 months


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ UK study suggests Covid-19 vaccine gives immunity for 5 months
SIREN research study came up with the post-vaccine results in UK

People who have been infected with Covid-19 are likely to be protected against catching it again for at least five months, according to a new study led by Public Health England (PHE).

The study -- which has not yet been peer-reviewed -- found that past infection was linked to an 83% lower risk of reinfection, compared to people who have not been infected before. But researchers warned that the protection was not absolute, meaning some people do catch the virus again and that it was unclear how long any immunity lasts. It is also possible that those who have a degree of immunity against the virus may still be able to carry the virus in their nose or throat and therefore transmit it to others.
"We now know that most of those who have had the virus, and developed antibodies, are protected from reinfection, but this is not total and we do not yet know how long protection lasts," Susan Hopkins, senior medical adviser at PHE and co-leader of the study, said in a statement.
"Even if you believe you already had the disease and are protected, you can be reassured it is highly unlikely you will develop severe infections. But there is still a risk you could acquire an infection and transmit (it) to others," Hopkins said.
The SIREN research study regularly tested almost 21,000 health workers from across the UK between June and November. Among them, 6,614 people participants tested positive for antibodies against the virus, while more than 14,000 had no signs of the previous infection.
But of those who had been infected, 44 developed possible new infections -- representing an 83% level of protection against reinfection.
The study will continue to monitor healthcare workers for 12 months to see if protection lasts even longer, but for now, the length of protection identified means that people who caught the virus in the first wave of infections may now be able to catch it again. It will also look into the impact of the new variant and the effectiveness of Covid-19 vaccines.
But early insight from the next stage of the study shows that some people with existing immunity carry high levels of virus and could transmit the virus to others.

Hopkins highlighted this during an interview with the BBC's Today program on Thursday.
"We found people with very high amounts of virus in their nose and throat swabs, that would easily be in the range which would cause levels of transmission to other individuals."


Hopkins stressed that people who had previously caught Covid-19 still needed to obey social distancing rules to avoid transmitting the disease.
"The SIREN study has major implications for how we can get out of the current crisis. The good news is that this study gives further weight that reinfections of Covid are rare, at least at this stage, and that having antibodies will provide protection for a meaningful amount of time, although it may not be lifelong immunity," Dr Simon Clarke, Associate Professor in Cellular Microbiology, University of Reading, told the Science Media Centre.
"The concerning finding is that some people who have Covid antibodies appear to still be able to carry the coronavirus and could spread it to others. This means that the vast majority of the population will either need to have natural immunity or have been immunised for us to fully lift restrictions on our lives," he said.
Lawrence Young, Virologist and Professor of Molecular Oncology, Warwick Medical School added that because the results cover the months before the new variant took hold, "it will be important to determine whether the previous infection with the old virus variant is able to offer protection from re-infection with the new virus variant."
England is currently under a stringent national lockdown after cases surged over the holiday period. The UK has recorded more than 3.2 million cases of infection.

https://edition.cnn.com/2021/01/14/health/covid-immunity-antibodies-intl/index.html 

Tags : #SignalResesrchStudy #UKVaccineReport #MolecularOncology #CellularMicrobiology #WarwickMedicalSchool #VaccineandImmunity #PublicHealthEngland

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026